drugset / Trial / NCT04231539

Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study

NCT04231539

RandomizedFactorialDouble-blindPrevention

Summary

This trial studies activity of time (pharmacokinetics), subjective effects, and abuse liability of nicotine salt-based vaping products with tobacco or e-liquids. This study aims to determine and compare the levels of nicotine delivered to the bloodstream from nicotine salt and free-base nicotine e-liquid solutions.

Timeline

Start
2020-02-18
Primary completion
2024-07-10
Completion
2024-07-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 25.5 mg/ml Inhaled

Indications